CSIMarket
 
Irhythm Technologies Inc   (NASDAQ: IRTC)
Other Ticker:  
 
 
Price: $106.6400 $0.00 0.000%
Day's High: $107.355 Week Perf: 3.9 %
Day's Low: $ 104.89 30 Day Perf: 0.04 %
Volume (M): 253 52 Wk High: $ 128.52
Volume (M$): $ 27,023 52 Wk Avg: $90.32
Open: $106.42 52 Wk Low: $55.92



 Market Capitalization (Millions $) 3,328
 Shares Outstanding (Millions) 31
 Employees 2,000
 Revenues (TTM) (Millions $) 592
 Net Income (TTM) (Millions $) -113
 Cash Flow (TTM) (Millions $) 392
 Capital Exp. (TTM) (Millions $) 34

Irhythm Technologies Inc
iRhythm Technologies Inc, founded in 2006, is a healthcare technology company that provides remote cardiac monitoring solutions. The company offers two key product lines: Zio XT and IQVIA. These products help physicians diagnose patients with heart arrhythmias and monitor their heart activity outside of the hospital.

Zio XT is a continuous wearable cardiac monitor that patients wear for up to 14 days. It allows physicians to collect more data than traditional Holter monitors - which can only be worn for 24-48 hours. The device can be worn during normal daily activities, including showering and sleeping, and it provides continuous ECG recordings which can be accessed remotely by physicians. These recordings help doctors diagnose cardiac arrhythmias.

IQVIA, on the other hand, is an AI-powered platform that uses machine learning algorithms to analyze large amounts of patient data to identify potential cardiac arrhythmias. It can use data from various sources such as EHRs, mobile devices, and wearables such as the Zio XT. The platform enables healthcare practitioners to personalize treatment for patients based on their individual needs and risk factors.

The company's products have received FDA clearance and are recognized as one of the most advanced cardiac monitoring technologies available. They have also been featured in several clinical studies, including a trial that demonstrated the effectiveness of Zio XT in diagnosing atrial fibrillation.

iRhythm Technologies Inc's headquarters are in San Francisco, California, but they also have additional offices in Minnesota, North Carolina, and internationally in Germany and the UK. The company is listed on NASDAQ with ticker symbol "IRTC". They continue to expand their product offerings and partnerships with other healthcare providers to improve patient outcomes and reduce unnecessary hospital visits.


   Company Address: 699 8th Street San Francisco 94103 CA
   Company Phone Number: 632-5700   Stock Exchange / Ticker: NASDAQ IRTC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BAX        2.47% 
BSX        1.68% 
EW        8.26% 
IART   -0.84%    
LIVN        3.66% 
MDT        0.47% 
• View Complete Report
   



Product Service News

iRhythm Technologies? AI-Driven ECG System Gains Approval in Japan, Demand Grows Amid Revenue Records,

Published Wed, Sep 11 2024 12:05 PM UTC

iRhythm Technologies Secures Japanese Regulatory Approval for AI-Powered Zio ECG Monitoring System Amid Impressive Revenue GrowthiRhythm Technologies Inc. has announced an essential milestone in its expansion efforts with the recent regulatory approval of its Zio ECG Monitoring System in Japan. This marks the first product in the healthcare sector to offer arrhythmia monito...

Licensing Agreement

iRhythm Technologies Partners with BioIntelliSense to Enhance Ambulatory Cardiac Monitoring with Innovative Sensor Te...

Published Wed, Sep 4 2024 11:30 AM UTC

iRhythm Technologies Enters License Agreement with BioIntelliSense for Advanced Ambulatory Cardiac Monitoring Solutions In a strategic move that stands to enhance the capabilities of ambulatory cardiac monitoring (ACM), iRhythm Technologies has entered into a licensing agreement with BioIntelliSense. This agreement grants iRhythm exclusive rights to BioIntelliSense?s patente...

Clinical Study

iRhythm Technologies Surpasses Expectations GUARD-AF Trial Results and Revenue Growth Signal Promise for Cardiac Care

Published Sun, Sep 1 2024 5:33 PM UTC

At the recent European Society of Cardiology (ESC) Congress 2024, iRhythm Technologies Inc. unveiled its groundbreaking findings from the GUARD-AF trial, marking a significant milestone in the realm of cardiac care. This pivotal study investigated the efficacy of long-term monitoring in patients with atrial fibrillation (AF), a condition that affects millions globally and po...

Product Service News

iRhythm Technologies Pioneering Cardiac Monitoring in Europe Amid Financial Challenges,

Published Thu, Aug 29 2024 12:00 PM UTC

iRhythm Technologies, Inc. (NASDAQ: IRTC), a prominent player in the digital healthcare arena, has recently made strides in its international expansion by launching its Zio cardiac arrhythmia monitoring service across four key European markets: Austria, the Netherlands, Switzerland, and Spain. This launch reflects the growing demand for advanced cardiac monitoring solutions ...

Product Service News

iRhythm Technologies Manufacturing Automation Sets Course for Growth and Cost Savings

Published Mon, Jun 17 2024 8:06 PM UTC

In a major development for iRhythm Technologies, the leading digital healthcare company has successfully commenced the initial phases of its manufacturing automation plans. This achievement not only signifies a significant operational milestone but also holds immense potential for future growth, innovation, and substantial cost savings.iRhythm Technologies, Inc. has establis...







Irhythm Technologies Inc's Segments
Contracted third-party payors    52.39 % of total Revenue
Centers for Medicare and Medicaid    24.42 % of total Revenue
Healthcare institutions    15.91 % of total Revenue
Non-contracted third-party payors    7.33 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com